HEALTH OF WOMAN. 2019.4(140): 92–95; doi 10.15574/HW.2019.140.92

Сумцов Д. Г., Кузьоменська М. Л., Сумцов Г. О.
Медичний інститут Сумського державного університету

У даному огляді літератури представлений аналіз сучасного стану проблеми раку яєчників та шляхи її можливого вирішення. Згідно з клінічними спостереженнями та проведеними в останні десятиліття морфологічними, імуногістохімічними і молекулярно-генетичними дослідженнями, досить вірогідно доведено, що першопричиною серозного раку яєчників є патологія слизової оболонки маткової труби. У матковій трубі як наслідок циркуляції елементів запалення і канцерогенів виникає дисплазія слизової оболонки з розвитком преінвазивної і початкової інвазивної карциноми з наступним ураженням яєчників та очеревини таза. Ретроспективні дослідження стану здоров’я значної кількості жінок, яким у попередні роки були проведені перев’язки або видалення маткових труб, засвідчили зниження захворюваності на серозний рак яєчників від 30 до 90%. Зроблені висновки щодо можливості профілактики раку яєчників шляхом опортуністичної сальпінгектомії у пострепродуктивному віці. У багатьох країнах світу (Канада, Китай, Франція, Італія, Австрія) розпочато впровадження такого методу профілактики. Вважаємо, що і в Україні назріла необхідність і наявні всі можливості вирішення цієї проблеми.
Ключові слова: рак яєчників, профілактика, опортуністична сальпінгектомія.

ЛЫТЕРАТУРА:

Absaturova AV, Yezhova LS, Faisullina NM et al. 2016. Morphological and immunohistochemical characteristics of changes in the mucous membrane of the fallopian tube during epithelial ovarian tumors. Arch. Pathol. 2: 3-9. https://doi.org/10.17116/patol20167823-9; PMid:27070769

Bulletin of the National Cancer Registry Ukraine 19. Cancer in Ukraine, 2016-2017 edited by OO Kolesnik . National Cancer Institute. K:130. 2017.

Zhordania KI, Payanidi UG, Kalinicheva EV. 2014. New paradigm of ovarian cancer etiology Russian Biotherapeutic Journal 13(2): 95-102.

Sumtsov GA, Sumtsov DG. 2015. Primary cancer of the fallopian tubes: monograph.Sumy: Sumy State University:229.

Chen Y, Du H, Bao L, Liu W. (2018 Jan) Opportunistic salpingectomy at benign gynecological surgery for reducing ovarian cancer risk: a 10-year single centre experience from China and a literature review. J Cancer. 1;9(1):141-147. https://doi.org/10.7150/jca.21187; PMid:29290779 PMCid:PMC5743721

Chene G1, de Rochambeau B2, Le Bail-Carval K et al. 2016, Jul-Aug. Current surgical practice of prophylactic and opportunistic salpingectomy in France. Gynecol Obstet Fertil. 44(7-8):377-84. https://doi.org/10.1016/j.gyobfe.2016.05.003; PMid:27363615

Cibula D, Widschwendter M, Majek O, Dusek L. 2011. Tubal ligation and the risk of ovarian cancer:review and meta-analysis.Hum Reprod Update 17(1):55–67. https://doi.org/10.1093/humupd/dmq030; PMid:20634209

James R. Conner, Emily Meserve Ellen Pizer, Judy Garber et al. .2014, Feb. Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutationsGynecol Oncol. 132(2): 280–286.  https://doi.org/10.1016/j.ygyno.2013.12.009; PMid:24333842 PMCid:PMC3932113

Cress RD, Chen YS, Morris CR, Petersen M & Leiserowitz GS. 2015. Characteristics of long-term survivors of epithelial ovarian cancer. Obstet. Gynecol. 126:491–497. https://doi.org/10.1097/AOG.0000000000000981; PMid:26244529 PMCid:PMC4545401

Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y. 2007. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res. 5:35–44. (PMC free article) (PubMed). https://doi.org/10.3121/cmr.2007.702; PMid:17456833 PMCid:PMC1855333

Erickson BK, Conner MG, Landen CN Jr. 2013. The role of the fallopian tube in the origin of ovarian cancer. Am J Obstet Gynecol. 209 (5):409-14. https://doi.org/10.1016/j.ajog.2013.04.019; PMid:23583217 PMCid:PMC3937451

Findley AD, Siedhoff MT, Hobbs KA, Steege JF, Carey ET, McCall CA et al. 2013. Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial. Fertil Steril. 100:1704–1708. https://doi.org/10.1016/j.fertnstert.2013.07.1997; PMid:23993887 PMCid:PMC3844119

Kezia Gaitskell, Kate Coffey, Jane Green, Kirstin Pirie et al. 2016, Apr 26. Tubal ligation and incidence of 26 site-specific cancers in the Million Women Study.Br J Cancer. 114(9): 1033–1037. https://doi.org/10.1038/bjc.2016.80; PMid:27115569 PMCid:PMC4984917

Garcia C, Martin M, Tucker LY, Lyon L, Armstrong MA, McBride-Allen S et al. 2016. Experience with opportunistic salpingectomy in a large, community-based health system in the United States. Obstet Gynecol. 128:277–283. https://doi.org/10.1097/AOG.0000000000001531; PMid:27399999

Sophia HL, George Ruslan Garcia and Brian M. Slomovitz. 2016. Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention.Front Oncol. 6:108. https://doi.org/10.3389/fonc.2016.00108; PMid:27200296 PMCid:PMC4852190

Havrilesky LJ, Moorman PG, Lowery WJ, Gierisch JM et al. 2013, Jul. Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis. Obstet Gynecol. 122(1):139-47. https://doi.org/10.1097/AOG.0b013e318291c235; PMid:23743450

Kindelberger DW1, Lee Y, Miron A, Hirsch MS, Feltmate C et al. 2007, Feb. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol. 31(2):161-9. https://doi.org/10.1097/01.pas.0000213335.40358.47; PMid:17255760

Kurman RJ1, Shih IeM. 2011, Jul. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer–shifting the paradigm. Hum Pathol. 42(7):918-31. https://doi.org/10.1016/j.humpath.2011.03.003; PMid:21683865 PMCid:PMC3148026

Kurman RJ, Shih IeM. 2016, Apr. The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and ExpandedAm J Pathol. 186(4):733-47. https://doi.org/10.1016/j.ajpath.2015.11.011; PMid:27012190 PMCid:PMC5808151

Kwon JS, Tinker A, Pansegrau G, McAlpine J et al. 2013, Jan. Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers. Obstet Gynecol. 121(1):14-24. https://doi.org/10.1097/AOG.0b013e3182783c2f; PMid:23232752

Intidhar Labidi-Galy S, Eniko Papp, […]Victor E. Velculescu. 2017. High grade serous ovarian carcinomas originate in the fallopian tube Nature 8;1093. https://doi.org/10.1038/s41467-017-00962-1; PMid:29061967 PMCid:PMC5653668

Lee Y, Miron A, Drapkin R, Nucci MR et al. 2007, Jan. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 211(1):26-35. https://doi.org/10.1002/path.2091; PMid:17117391

Madsen C, Baandrup L, Dehlendorff C, Kjaer SK. 2015, Jan. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study. Acta Obstet Gynecol Scand. 94(1):86-94. https://doi.org/10.1111/aogs.12516; PMid:25256594

McAlpine JN, Hanley GE, Woo MM, Tone AA et al. 2014, May. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention. Am J Obstet Gynecol. 210(5):471.e1-11. https://doi.org/10.1016/j.ajog.2014.01.003; PMid:24412119

Medeiros F1, Muto MG, Lee Y, Elvin JA et al. 2006, Feb. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 30(2):230-6. https://doi.org/10.1097/01.pas.0000180854.28831.77; PMid:16434898

Mittal N, Srinivasan R, Gupta N, Rajwanshi A et al. 2016, Oct-Dec. Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma. Indian J Pathol Microbiol. 59(4):481-488. https://doi.org/10.4103/0377-4929.191789; PMid:27721278

Mohamed AA, Yosef AH, James C, Al-Hussaini TK et al. 2017, Jul. Ovarian reserve after salpingectomy: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 96(7):795-803. https://doi.org/10.1111/aogs.13133; PMid:28471535

Narod SA, Sun P, Ghadirian P, Lynch H, Isaacs C, Garber J et al. 2001. Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet 357(9267):1467–70. (PubMed) (Cross Ref). https://doi.org/10.1016/S0140-6736(00)04642-0

Nezhat FR. 2015. New insights in the pathophysiology of ovarian cancer and implications for screening and prevention. Am J Obstet Gynecol 213(3):262-7. https://doi.org/10.1016/j.ajog.2015.03.044; PMid:25818671

Piek JM, Verheijen RH, Kenemans P, Massuger LF et al. 2003, Aug. BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis. Gynecol Oncol. 90(2):491. https://doi.org/10.1016/S0090-8258(03)00365-2

Piek JM. et al. 2001. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J. Pathol. 195:451–456. https://doi.org/10.1002/path.1000; PMid:11745677

Potz FL, Tomasch G, Polterauer S, Laky R, Marth C, Tamussino K. 2016. Incidental (prophylactic) salpingectomy at benign gynecologic surgery and cesarean section: a survey of practice in Austria. Geburtshilfe Frauenheilkd. 76:1325–1329. https://doi.org/10.1055/s-0042-116493; PMid:28017973 PMCid:PMC5177549

Przybycin CG1, Kurman RJ, Ronnett BM et al. 2010, Oct. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol. 34(10):1407-16. https://doi.org/10.1097/PAS.0b013e3181ef7b16; PMid:20861711

Przybycin CG1, Kurman RJ, Ronnett BM et al. 2010, Oct. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol. 34(10):1407-16. https://doi.org/10.1097/PAS.0b013e3181ef7b16; PMid:20861711

Rice MS1, Murphy MA, Tworoger SS. 2012, May. Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis. J Ovarian Res. 15;5(1):13. https://doi.org/10.1186/1757-2215-5-13; PMid:22587442 PMCid:PMC3386864

Salvador S, Gilks B, Köbel M, Huntsman D, Rosen B, Miller D. 2009. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer. 19(1):58-64. https://doi.org/10.1111/IGC.0b013e318199009c; PMid:19258943

Siegel RL, Miller KD, Jemal A. 2015, Jan-Feb. Cancer statistics, 2015. CA Cancer J Clin. 65(1):5-29. https://doi.org/10.3322/caac.21254; PMid:25559415

Sieh W, Salvador S, McGuire V, Weber RP et al. 2013, Apr. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. Int J Epidemiol. 42(2):579-89.

Soegaard M, Jensen A, Høgdall E, Christensen L et al. 2007, Jun. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study. Cancer Epidemiol Biomarkers Prev. 16(6):1160-6. https://doi.org/10.1158/1055-9965.EPI-07-0089; PMid:17548679

Karl Tamussino. 2017, Jul. Should national societies recommend opportunistic salpingectomy? J Gynecol Oncol 28(4): e53. https://doi.org/10.3802/jgo.2017.28.e53; PMid:28541640 PMCid:PMC5447151

Tone AA, Salvador S, Finlayson SJ, Tinker AV et al. 2012, May. The role of the fallopian tube in ovarian cancer. Clin Adv Hematol Oncol. 10(5):296-306.

Lindsey A. Torre, Carol E. DeSantis, Kimberly D. Miller, Ahmedin Jemal et al. 2018. Ovarian cancer statistics, 2018. CA Cancer J Clin. 68:284–296. https://doi.org/10.3322/caac.21456; PMid:29809280 PMCid:PMC6621554

Venturella R, Rocca M, Lico D, Trapasso S et al. 2016. Prophylactic bilateral salpingectomy for the prevention of ovarian cancers: what is happening in Italy? Eur J Cancer Prev 25:410–415. https://doi.org/10.1097/CEJ.0000000000000191; PMid:26275007

Venturella R, Morelli M, Lico D, Di Cello A et al. 2015, Nov. Wide excision of soft tissues adjacent to the ovary and fallopian tube does not impair the ovarian reserve in women undergoing prophylactic bilateral salpingectomy: results from a randomized, controlled trial. Fertil Steril. 104(5):1332-9. https://doi.org/10.1016/j.fertnstert.2015.08.004; PMid:26335129

Zweemer RP, van Diest PJ, Verheijen RH, Ryan A, Gille JJ et al. 2000. Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations.Gynecol Oncol. 76(1):45-50. https://doi.org/10.1006/gyno.1999.5623; PMid:10620440